期刊文献+

PARP-1基因多态性与胃癌易感性的关系 被引量:5

Association between PARP-1 polymorphisms and susceptibility to gastric cancer
下载PDF
导出
摘要 探讨聚腺苷二磷酸核糖聚合酶-1(PARP1)Val762 Ala,Lys 940Arg基因多态性与甘肃省地区汉族人群胃癌易感性的关系.方法:采用多重单碱基延伸SNP分型技术(Multiplex SNaPshot)对甘肃省胃癌高发区河西地区汉族人群中经病理确诊的原发性胃癌150例,健康对照组152例进行PARP-1基因2个SNP位点基因分型.使用ELISA法检测H.pylori感染.结果:发现PARP-1940Lys/Arg基因型分布在胃癌组明显高于对照组(OR=2.917,95%CI1.430-5.947,P=0.002);PARP-1762Val/Al基因型分布在胃癌组明显高于对照组(OR=1.685,95%CI:1.040-2.729,P=0.034).分层分析显示,在吸烟人群中,PARP-1940 Lys/Arg基因型携带者患胃癌的风险是Lys/Lys型携带者的8.430倍(OR=8.340;95%CI:2.664-26.144P=0.000);在饮酒人群中,PARP-1940LysA r g基因型携带者患胃癌的风险是Ly s/Ly型携带者的3.333倍(OR=3.333,95%CI1.214-9.155,P=0.015),在H.pylori感染阳性人群中,PARP-1762Ala/Ala基因型携带者患胃癌的风险是Val/Val携带者的2.360倍(OR=2.360,95%CI:1.256-4.433,P=0.007).同时携带PARP-1940Lys/Arg和PARP-1762AlaAla+Val/Ala基因型的个体患胃癌的发病风险是PARP-1940Lys/Lys和PARP-1762Val/Va基因型携带者的4.2倍(OR=4.200,95%CI1.430-12.338,P=0.006).结论:PARP-1 940Lys/Arg和PARP-1 762AlaAla或Ala/Ala基因型与中国甘肃地区汉族人群胃癌发病风险增高相关;PARP-1Lys940Ar与吸烟,饮酒,PARP-1Val762Ala与H.pylor感染以及PARP-1Lys940Arg与PARP-Val762Ala在胃癌的发病风险中都各自存在着加乘交互效应. AIM:To investigate the association between the Val762Ala and Lys940Arg polymorphisms of the poly(ADP-ribose) polymerase-1(PARP-1) gene and susceptibility to gastric cancer in a Chinese Han population in He'xi area of Gansu Province.METHODS:All investigated subjects were divided into two groups:150 gastric cancer patients and 152 controls.The SNaPshot single nucleotide polymorphism(SNP) genotyping method was used to analyze the genotypes of PARP-1 Val762Ala and Lys940Arg.Helicobacter pylori(H.pylori) IgG antibody was detected by enzyme-linked immunosorbent assay(ELISA).The results were analyzed using the SPSS16.0 software package.RESULTS:PARP-1 940 Lys/Arg and 762 Val/Ala genotypes were overrepresented in gastric cancer patients compared with controls(OR=2.917 and 1.685;95%CI:1.430-5.947 and 1.040-2.729;P=0.002 and 0.034,respectively).In smoking subjects,the risk of gastric cancer in PARP-1 940 Lys/Arg genotype carriers was 8.430-fold higher than that in Lys/Lys carriers(OR=8.340,95%CI:2.664-26.144,P=0.000).In drinking subjects,PARP-1 940 Lys/Arg genotype carriers had a 3.333-fold higher risk of gastric cancer than Lys/Lys carriers(OR=3.333,95%CI:1.214-9.155,P=0.015).In H.pylori IgGpositive subjects,PARP-1 762 Ala/Ala genotype carriers had a 2.360-fold increased risk of gastric cancer than Val/Val carriers(OR=2.360,95%CI:1.256-4.433,P=0.007).The subjects carrying PARP-1 940 Lys/Arg and PARP-1 Ala/Ala or Val/Ala genotypes had a 4.2-fold increased risk of gastric cancer compared with those carrying PARP-1 940 Lys/Lys and PARP-1 762Val/Val genotypes(OR=4.200,95%CI:1.430-12.338,P=0.006).CONCLUSION:PARP-1 940Lys/Arg and PARP-1 762Ala/Ala or Ala/Ala genotypes are associated with a higher risk of gastric cancer.There are multiplicative joint effects between PARP-1 940 Lys/Arg genotype and smoking or drinking,between PARP-1 762 Val/Ala or Ala/Ala genotypes and H.pylori infection,and between PARP-1 Lys940Arg and PARP-1 Val762Ala genotypes in increasing the risk
出处 《世界华人消化杂志》 CAS 北大核心 2010年第14期1434-1441,共8页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30870364~~
关键词 胃癌 聚腺苷二磷酸核糖聚合酶-1 基因多态性 Gastric cancer Poly(ADP-ribose) polymerase-1 Polymorphism
  • 相关文献

参考文献8

二级参考文献114

共引文献419

同被引文献58

  • 1胡品津.基因多态性与胃癌遗传易感性的关系[J].中华消化杂志,2006,26(4):278-279. 被引量:11
  • 2Ghosh U, Bhattacharyya N P. Induction of apoptosis by the inhibitors of poly (ADP-ribose) polymerase in HeLa cells[J]. Mol Cell Biochem, 2009, 320(1-2) :15-23. 被引量:1
  • 3Figueroa J D, Malats N, Real F X, et al. Genetic variation in the base excision repair pathway and bladder cancer dsk[J]. Hum Genet, 2007, 121(2) :233-242. 被引量:1
  • 4Cimmino G, Pepe S, Laus G, et al. Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54p53wt and U251p53mut glioblastoma cell lines[J]. Pharmacol Res, 2007, 55 (1) :49-56. 被引量:1
  • 5Ratnam K, Low J A. Current development of clinical inhibitors of poly (ADP-ribose) polymerase in oncology [J]. Clin Cancer Res, 2007, 13(5) :1383-1388. 被引量:1
  • 6Farmer H, McCabe N, Lord C J, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [ J ]. Nature, 2005, 434 (7035) : 917 -921. 被引量:1
  • 7Fong P C, Boss D S, Yap T A, et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers[J]. N Engl J Med, 2009, 361 (2) :123- 134. 被引量:1
  • 8Nguewa P A, Fuertes M A, Cepeda V, et al. Poly (ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells [ J ]. Med Chem, 2006, 2 ( 1 ) :47-53. 被引量:1
  • 9Calabrese C R, Almassy R, Barton S, et al. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361[J ]. J Nail Cancer Inst, 2004, 96(1) :56-67. 被引量:1
  • 10Dykxhoorn D M, Palliser D, LiebermanJ. The silent treatment: siRNAs as small molecule drugs [ J ]. Gene Therapy, 2006,13 (6) :541-552. 被引量:1

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部